Acquisitions (Tables)

12 Months Ended

Dec. 31, 2020

ARTeSYN Biosolutions

Schedule of Business Combination Consideration Transferred

Total consideration transferred is as follows (amounts in thousands):

Cash consideration	$	130,713
Equity consideration		69,422
Contingent consideration		1,548
Settlement of preexisting liabilities		2,310
Fair value of net assets acquired	$	203,993

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and estimated allocation of the purchase price consists of the following amounts (amounts in thousands):

Cash and cash equivalents	$	2,982
Accounts receivable		4,811
Inventory		8,592
Prepaid expenses and other current assets		5,561
Property and equipment		1,836
Operating lease right of use asset		1,611
Other noncurrent assets		26
Customer relationships		38,400
Developed technology		27,060
Trademark and tradename		1,630
Non-competition agreements		300
Goodwill		128,658
Accounts payable		(2,161	)
Accrued liabilities		(8,856	)
Deferred revenue		(3,583	)
Deferred tax liabilities, net		(1,240	)
Notes payable		(24	)
Operating lease liability		(417	)
Operating lease liability, long-term		(1,193	)
Fair value of net assets acquired	$	203,993

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the ARTeSYN Acquisition and their estimated useful lives:

	Useful life		Fair Value
			(Amounts in thousands)
Customer relationships		17 years	$	38,400
Developed technology		15 years		27,060
Trademark and tradename		21 years		1,630
Non-competition agreements		3 years		300
			$	67,390

Non-Metallic Solutions

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and estimated allocation of the purchase price consist of the following amounts (amounts in thousands):

Cash and cash equivalents	$	1,163
Accounts receivable		415
Inventory		334
Prepaid expenses and other current assets		13
Property and equipment		73
Operating lease right of use asset		194
Customer relationships		6,370
Developed technology		1,810
Trademark and tradename		190
Non-competition agreements		90
Goodwill		6,784
Deferred tax assets		24
Accounts payable		(96	)
Accrued liabilities		(999	)
Operating lease liability		(136	)
Operating lease liability, long-term		(59	)
Fair value of net assets acquired	$	16,170

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the NMS Acquisition and their estimated useful lives:

	Useful life		Fair Value
			(Amounts in thousands)
Customer relationships		14 years	$	6,370
Developed technology		12 years		1,810
Trademark and tradename		15 years		190
Non-competition agreements		3 years		90
			$	8,460

Engineered Molding Technology LLC

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and allocation of the purchase price consist of the following amounts (amounts in thousands):

Cash and cash equivalents	$	69
Accounts receivable		1,057
Inventory		449
Prepaid expenses and other current assets		7
Property and equipment		472
Operating lease right of use assets		1,050
Customer relationships		11,080
Developed technology		2,910
Trademark and tradename		320
Non-compete agreements		50
Goodwill		12,585
Accounts payable		(283	)
Accrued liabilities		(202	)
Operating lease liability		(211	)
Operating lease liability, long-term		(839	)
Fair value of net assets acquired	$	28,514

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the EMT Acquisition and their estimated useful lives:

	Useful life		Fair Value
			(Amounts in thousands)
Customer relationships		14 years	$	11,080
Developed technology		11 years		2,910
Trademark and tradename		14 years		320
Non-competition agreements		3 years		50
			$	14,360

C Technologies, Inc.

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and allocation of the purchase price consists of the following amounts (amounts in thousands):

Cash and cash equivalents	$	3,795
Restricted cash		26,933
Accounts receivable		3,044
Inventory		3,783
Prepaid expenses and other current assets		93
Fixed assets		40
Operating lease right of use asset		3,836
Customer relationships		59,680
Developed technology		28,920
Trademark and tradename		1,570
Non-competition agreements		660
Goodwill		142,314
Deferred taxes		895
Accounts payable		(436	)
Accrued liabilities		(2,767	)
Accrued bonus		(26,928	)
Deferred revenue		(1,709	)
Operating lease liability		(51	)
Operating lease liability, long-term		(3,785	)
Fair value of net assets acquired	$	239,887

Unaudited Supplemental Pro Forma Information

The following pro forma financial information does not reflect any adjustments for anticipated expense savings resulting from the acquisition and is not necessarily indicative of the operating results that would have actually occurred had the transaction been consummated on January 1, 2019 or of future results (amounts in thousands, except per share data):

	December 31,
	2019		2018
Total revenue	$	279,434	$	217,739
Net income	$	23,394	$	21,195
Earnings per share:
Basic	$	0.48	$	0.44
Diluted	$	0.48	$	0.43